PRINCIPAL FINANCIAL GROUP INC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1126328 DES MOINES, IA

Position in EWTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$222,246

-$13,396 QoQ

Shares Held

5,470

-58.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#163

of 223 holders

Holding Since

Dec 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. EWTX ranks #82 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$222,246	5,470	-58.2%	Shares	Defined	2026-08-04
2024-06-30	$235,642	13,084	-22.0%	Shares	Defined	2024-07-29
2024-03-31	$305,792	16,765	+2.2%	Shares	Defined	2024-04-29
2023-12-31	$179,415	16,400	-6.6%	Shares	Defined	2024-02-07
2023-09-30	$100,623	17,561	+9.2%	Shares	Defined	2023-11-02
2023-06-30	$124,634	16,082	+32.1%	Shares	Defined	2023-08-07
2023-03-31	$81,226	12,178	+11.2%	Shares	Defined	2023-05-09
2022-12-31	$97,875	10,948	—	Shares	Defined	2023-02-09
No filing history on record for this holder in this stock.